Dolby Laboratories (NYSE:DLB) Updates Q1 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its first quarter earnings guidance on Tuesday. The company provided EPS guidance of $0.53-0.68 for the period, compared to the consensus EPS estimate of $0.84. The company issued revenue guidance of $330-360 million, compared to the consensus revenue estimate of $337.94 million. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.

Analysts Set New Price Targets

DLB has been the topic of a number of analyst reports. Barrington Research reissued an “outperform” rating and set a $100.00 price objective on shares of Dolby Laboratories in a research note on Wednesday. StockNews.com upgraded Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Monday. Finally, Rosenblatt Securities raised their price objective on Dolby Laboratories from $98.00 to $100.00 and gave the company a “buy” rating in a research report on Wednesday.

Dolby Laboratories Stock Performance

Shares of DLB stock opened at $80.31 on Friday. The stock has a fifty day simple moving average of $74.15 and a two-hundred day simple moving average of $76.08. Dolby Laboratories has a 52-week low of $66.35 and a 52-week high of $90.06. The firm has a market capitalization of $7.66 billion, a PE ratio of 29.63 and a beta of 0.98.

Dolby Laboratories Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 10th. Investors of record on Tuesday, December 3rd will be given a $0.33 dividend. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date of this dividend is Tuesday, December 3rd. Dolby Laboratories’s dividend payout ratio is 44.28%.

Dolby Laboratories declared that its board has approved a stock repurchase program on Wednesday, August 7th that permits the company to buyback $350.00 million in outstanding shares. This buyback authorization permits the electronics maker to purchase up to 5% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s leadership believes its stock is undervalued.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 28,512 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the completion of the sale, the chief executive officer now directly owns 83,721 shares in the company, valued at approximately $6,205,400.52. The trade was a 25.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 39.54% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.